statistiche ricercatore

Città	#
Singapore	109
Chandler	77
Dublin	57
Hong Kong	40
San Jose	30
Jacksonville	28
San Mateo	27
Dong Ket	19
Santa Clara	17
Ashburn	16
Seoul	16
Munich	15
Altamura	14
Boardman	12
Medford	11
Princeton	11
Lauterbourg	10
Moscow	10
The Dalles	10
Wilmington	10
Beijing	9
Ho Chi Minh City	9
Lawrence	9
Andover	8
Los Angeles	7
Hanoi	6
New York	5
Orem	5
São Paulo	5
Brussels	4
Izmir	4
Tokyo	4
Ann Arbor	3
Cormano	3
Poplar	3
Toronto	3
Amelia	2
Amsterdam	2
Ankara	2
Brno	2
Chennai	2
Denver	2
Guayaquil	2
Haiphong	2
Johannesburg	2
Lahore	2
Livorno	2
Manchester	2
Mcallen	2
Ottawa	2
Perugia	2
Piscataway	2
Riyadh	2
Tashkent	2
Turku	2
Warsaw	2
Ahmedabad	1
Amparo	1
Annapolis	1
Araure	1
Ardabil	1
Asunción	1
Atlanta	1
Azcapotzalco	1
Baghdad	1
Barra do Garças	1
Bismarck	1
Biên Hòa	1
Bogotá	1
Borrazópolis	1
Boydton	1
Brooklyn	1
Carmópolis	1
Casablanca	1
Chicago	1
Chisinau	1
Columbus	1
Conceição das Alagoas	1
Curitiba	1
Da Nang	1
Diamantina	1
Divino	1
Dolores	1
Figueira da Foz Municipality	1
Florence	1
Florianópolis	1
Fortaleza	1
Frankfurt am Main	1
Groningen	1
Guarulhos	1
Guatemala City	1
Gunzenhausen	1
Helsinki	1
Houston	1
Iloilo City	1
Itajaí	1
Iztapalapa	1
Jeddah	1
João Pessoa	1
Junín	1
Totale	710

Nome	#
Oxime and Oxime Ether Derivatives of 1,4-Benzothiazine Related to Oxiconazole.	127
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?	121
a-Amino-b-carboxymuconate-e-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of de Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis	118
Bulky 1,4-benzoxazine derivatives with antifungal activity	117
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids.	94
Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognition.	89
Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4).	88
Targeting the Conformational Transitions of MDM2 and MDMX. PART II: Insights into Key Residues Affecting p53 Recognition.	88
Use of an o-Benzyl-(S)-Serine Containing Eluent for the Efficient Ligand-Exchange Chromatography-Based Enantioseparation of Constrained Glutamate Receptor Ligands	87
Targeting the Conformational Transitions of MDM2 and MDMX. PART I: Insights into Dissimilarities and Similarities of p53 Recognition	83
Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition	77
Totale	1.089

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	29	0	0	0	0	0	0	0	0	0	0	7	22
2021/2022	81	3	18	2	0	2	0	0	31	0	2	12	11
2022/2023	203	11	42	2	18	18	21	0	7	71	0	11	2
2023/2024	79	3	13	3	2	2	0	11	0	18	1	14	12
2024/2025	169	8	15	20	5	11	18	0	3	32	9	28	20
2025/2026	367	25	35	13	53	61	34	60	23	39	24	0	0
Totale													1.089

IRIS - Res&Arch Institutional Research Information System - Research & Archive